WFSBP 2019 Final Program

43 Wednesday, 5 June 2019 / Scientific Program WFSBP 2019 WED aa Wednesday, 5 June 2019 T3: ANTIDEPRESSANTS: BASIC/CLINICAL S-42 SYMPOSIUM 08:15–09:45 Ballroom B/C Clinical translation of rapid acting antidepressants Chair: Samuel Wilkinson, USA Co-Chair: Sanjay Mathew, USA 001 Recent progress in the development of antidepres- sants targeting amino acid neurotransmitter systems Gerard Sanacora, USA 002 Neuroactive steroids in the treatment of mood disorders Steve Kanes, USA 003 Rapastinel: mechanism of action and update on clinical trials Suresh Durgam, USA 004 Esketamine: Clinical development trials for treat- ment resistant depression Jaskaran Singh, USA T7: BIPOLAR DISORDERS: BASIC/CLINICAL S-43 SYMPOSIUM 08:15–09:45 Ballroom A Where to place late-stage interventions in Bipolar Disorder (BD) guidelines? Chair: Flavio Kapczinski, Canada Co-Chair: Pedro Magalhaes, Brazil 001 Late-stage and refractory Bipolar Disorder (BD) treatment gaps Trisha Suppes, USA 002 Treatment interventions tailored for stage in BD Michael Berk, Australia 003 Clinical trial evidence for clozapine in (Bipolar Disorder) BD Pedro Magalhaes, Brazil 004 Naturalistic evidence, impact on public health and current guidelines Mauricio Kunz, Brazil T28: NEUROIMAGING: GENETIC, FUNCTIONAL, STRUCTURAL S-44 SYMPOSIUM 08:15–09:45 East Meeting Room 8/15 MRI-based prognostic assessments for early intervention: Are we there yet? Chair: Lena Palaniyappan, Canada Co-Chair: Stefan Borgwardt, Switzerland 001 Prognostic information and the anatomical hetero- geneity of first-episode psychosis Lena Palaniyappan, Canada 002 Early developmental and multivariate analyses of brain structure predict schizophrenia in the Edinburgh high risk study Stephen Lawrie, United Kingdom 003 Disorganized gyrification network properties during the transition to psychosis Andre Schmidt, Switzerland 004 Predicting functional disability in young adults at risk for psychosis and relapsing depression using multi- site, multi-modal machine learning: Results from the European PRONIA Project Nikolaos Koutsouleris, Germany T57: STIMULATION METHODS (E.G. ECT, TMS, VNS, DBS) S-45 SYMPOSIUM 08:15–09:45 East Meeting Room 13 Transcranial magnetic stimulation and magnetic seizure therapy in psychiatry Chair: Zafiris Daskalakis, Canada Co-Chair: Shirley Fecteau, Canada 001 Transcranial magnetic stimulation in treatment of youth depression Faranak Farzan, Canada 002 Magnetic seizure therapy reduces suicidal ideation and produces neuroplasticity in treatment-resistant depression Zafiris Daskalakis, Canada 003 Subgenual cingulate hyperactivity in depression is reversed by rTMS and MST Itay Hadas, Canada 004 rTMS on functional brain connectivity and cortisol levels in Posttraumatic Stress Disorder (PTSD) Shirley Fecteau, Canada